Experienced investors with recognized success in life sciences
For five decades, Kleiner Perkins (KP) has partnered with some of the most ingenious founders in technology and life sciences, helping them make history with their bold ideas. Through 20 venture funds and four growth funds KP has invested $10 billion in hundreds of companies including pioneers such as Amazon, Genentech, and Google. Today, Kleiner Perkins continues to invest in founders and their bold ideas helping them to make history.
Beth Seidenberg, MD is our co-founding investor and is a General Partner at KP, where she has primarily focused on life sciences investing since May 2005. She is also a managing director of Westlake Village BioPartners, a venture capital firm that focuses on life sciences that she founded in September 2018.
GV provides venture capital funding to bold new companies. Across the fields of life sciences, enterprise technology, consumer products and services, and frontier technology, GV's portfolio companies aim to improve lives and transform industries. GV's team of world-class engineers, designers, physicians, scientists, marketers, and investors work together to provide startups exceptional support.
Launched as Google Ventures in 2009, GV is the venture capital arm of Alphabet, Inc. GV helps startups interface with Google, providing unique access to the world’s best technology and talent.
GV has more than $4.5 billion under management. Among its investments are Uber, Lime, Slack and One Medical Group. Notable investment outcomes include Nest, Flatiron Health, and Duo Security. GV is headquartered in Mountain View, California, with offices in San Francisco, Boston, New York, and London.
Krishna Yeshwant, MD represents GV on our Board. He has been associated with a number of highly successful life science companies including Editas Medicine and Flatiron Health.